TAKASHI BABASAKI

Hiroshima University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Kohei Kobatake

Hiroshima University

JAPAN

View details

Keisuke Goto

Hiroshima University

JAPAN

View details

KENICHIRO IKEDA

Hiroshima University

JAPAN

View details

Junko Murai

Project Associate Professor

Keio University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

TAKASHI BABASAKI

Research Interests

Explore related searches

Contact this professor

Articles (10)

Histopathological Analysis of False-positive Lesions in mpMRI/TRUS Fusion Prostate Biopsy.

CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.

Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.

Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy.

P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.

Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.

Clinicopathologic features of TDO2 overexpression in renal cell carcinoma.

TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.

TUBB3 is associated with PTEN, neuroendocrine differentiation, and castration resistance in prostate cancer.

BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.

Collaborators (4)

Kohei Kobatake

Keisuke Goto

KENICHIRO IKEDA

Junko Murai

Make your next move.